Unlock instant, AI-driven research and patent intelligence for your innovation.

Multiparameter FACS assays to detect alterations in cellular parameters and screening

A cell parameter, cell technology, applied in the field of peptide and other chemical libraries, combinatorial chemical libraries, can solve the problem that a single receptor blocker cannot overcome the influence and so on

Inactive Publication Date: 2001-07-18
RIGEL PHARMA
View PDF11 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this approach is limited by the fact that a single receptor blocker cannot overcome the effects of many different mediators

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Multiparameter FACS assays to detect alterations in cellular parameters and screening
  • Multiparameter FACS assays to detect alterations in cellular parameters and screening
  • Multiparameter FACS assays to detect alterations in cellular parameters and screening

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0194] Cell cycle analysis using p21 as a positive control Materials and methods:

[0195] Vector construction: The coding region of the p21 gene was cloned from Jurkat cDNA by PCR with upstream primers covering the starting methionine (5'-GATCGGATCCACCACCATGGGCTC AGAACCGGCTGGGGATGTC) and the C-terminus (5'-GATCCCAATTTAATGGTTTTATTT GTCATCGTCATCCTTGTAGTCGGGCTTCCTCTTGGAGAAGATCAGCCGGCGTTTG). A single PCR product was directional cloned into the CRU5-GFP retroviral vector (Rigel Company) through the flanking BstX1 site in the primer. The resulting construct, CRU5-GFP-p21F ( figure 1 ), encoding GFP fused (in-frame) to the human p21 protein with a Gly inserted at position 2, with a FLAG-epitope at the C-terminus. 将p21的C-末端24个氨基酸通过PCR引物中的旁侧BstX1位点克隆到GRU5-GFP逆转录病毒载体(Rigel公司)中,所述PCR引物为:5′GATCCCACCACCATGGGCAAACGGCGGCAGACCAGCATGACAGATTTCTACCACTCCAAACGCC GGCTGATCTTCTCCAA; 5′GATCCCAATTTAAATGGTTTTATTTGTCATCGTCATCCTTGTAGTCGGGCTTCCTCTTGGAGAAG ATCAGCCGGCGTTTG. The resulting cons...

Embodiment 2

[0201] Population-Based Exocytase Activity Assay

[0202] Materials: All chemical reagents were obtained from Sigma Chemical Company. Dyes and glucuronides were obtained from Molecular Probes. Cell lines MC-9 and RBL-2H3 were obtained from the American Type Culture Collection (ATCC). Cell culture reagents were obtained from Fisher Scientific, and molecular biology reagents were obtained from Clontech.

[0203] Cell culture: MC-9 cells were loaded with L-arginine (116mg / ml), L-aspartic acid (36mg / ml), sodium pyruvate (1mM), non-essential amino acids (0.1mM), Folic acid (6mg / ml), 2-mercaptoethanol (0.05mM), L-glutamine (2mM), heat-inactivated fetal bovine serum (10%) in DMEM, and 10% T-stim conditioned medium (Collaborative Research , Inc.) as suspension cultures in shake flasks. Cell densities were maintained at 0.25 and 2 x 106 / ml. Experiments were performed on cells with greater than 95% cell viability as determined by trypan blue exclusion. Make RBL-2H3 c...

Embodiment 3

[0208] Example 3: Changes in Light Scattering of Mast Cell Exocytosis

[0209] Cells were prepared as described in Example 2, and light scattering properties were determined.

[0210] Results: The results are shown in Figure 4. Changes in light scatter (side scatter versus front scatter) observed by flow cytometry of RBL-2H3 cells (A, D) and MC-9 cells (B, C, E, F) are plotted as bivariate histograms. Cells were stimulated with ionophore A23187 (0.5 μg / ml) and observed at different time points [0 min (A,C), 5 min (E), 10 min (D), and 30 min (B,F)]. Time-dependent scatter changes were evident, with both cell lines changing significantly within the first 10 min, representing bulky exocytate in these cells.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
molecular weightaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention relates to novel methods of detecting alterations in cell cycle regulation in a cell or a cell population and screening for agents capable of modulating cell cycle regulation through the use of multiparameter assays and a fluorescence-activated cell sorter (FACS) machine.

Description

field of invention [0001] The present invention relates to a novel method for detecting changes in cell parameters using a fluorescence-activated cell sorting (FACS) instrument, especially for screening small molecule libraries, such as combinatorial chemical libraries of organic molecules, including peptides and other chemical libraries, that can bind target molecules. Background of the invention [0002] The field of drug discovery and screening of drug candidates to identify template compounds is rapidly evolving. Traditional methods of identifying and characterizing new and useful drug candidates involve isolating natural products or synthetic preparations followed by testing against known or unknown targets, see for example WO94 / 24314, Gallop et al., Journal of Medicinal Chemistry, 37(9): 1233(1994); Gallop et al., Journal of Medicinal Chemistry, 37(10):1385(1994); Ellman, Acc.Chem.Res.29:132(1996); Gordon et al., European Journal of Medicinal Chemistry, 30:388s(1994 )...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/02C12Q1/70G01N33/15G01N33/50G01N33/569
CPCG01N2333/4718G01N33/5014G01N33/502C12N15/1079G01N33/5044G01N33/5011G01N2333/43595G01N33/56966G01N33/5008
Inventor J·费舍尔J·劳伦斯D·帕严A·罗西
Owner RIGEL PHARMA